Stock listing

NASDAQ:RVNC Revance Therapeutics, Inc. Stock

Follow Revance Therapeutics, Inc. into a list and get an email when it puts out news.

Last close · NASDAQ:RVNC

$3.65 USD

Close on Feb 6, 2025 · No longer trades

Feb 6, 2014 to last close -86.4% · monthly closes, Feb 6, 2014 – Feb 6, 2025
Lowest – highest close
$2.34 – $40.78 USDSince Feb 6, 2014 · lowest Jun 26, 2024 · highest Nov 11, 2015

Delisted NASDAQ:RVNC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RVNC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Revance Therapeutics, Inc. news

Revance Therapeutics, Inc. on 6ix

News releases
1 in the last 12 months · 1 in all · newest Nov 16, 2026 · oldest 2026
Calls
13 calls with a replay · 13 with a transcript · latest May 9, 2024
Decks
10 decks · latest Sep 19, 2023

Events

CallWhenStatus
Revance Therapeutics (RVNC) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q4 2023 Earnings CallWed, Feb 28, 2024 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q2 2023 Earnings CallTue, Aug 08, 2023 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q1 2023 Earnings CallTue, May 09, 2023 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q4 2022 Earnings CallTue, Feb 28, 2023 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q3 2022 Earnings CallTue, Nov 08, 2022 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q2 2022 Earnings CallTue, Aug 09, 2022 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q1 2022 Earnings CallTue, May 10, 2022 · 7:30 PM ETReplay
Revance Therapeutics (RVNC) Q4 2021 Earnings CallMon, Feb 28, 2022 · 4:30 PM ETReplay
Revance Therapeutics (RVNC) Q3 2021 Earnings CallTue, Nov 09, 2021 · 7:30 PM ETReplay
All 13 calls
CallWhenStatus
Revance Therapeutics (RVNC) Q2 2021 Earnings CallThu, Aug 05, 2021 · 7:30 PM ETReplay
Revance Therapeutics (RVNC) Q1 2021 Earnings CallMon, May 10, 2021 · 7:30 PM ETReplay
Revance Therapeutics (RVNC) Q4 2020 Earnings CallMon, Feb 22, 2021 · 7:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Day (September 2023)Investor day112 slidesSep 19, 2023
Technical Presentation (October 2020)Technical28 slidesOct 14, 2020
Merger or Acquisition (May 2020)Merger or acquisition28 slidesMay 19, 2020
Technical Presentation (December 2018)Technical37 slidesDec 4, 2018
Investor Day (April 2018)Investor day106 slidesApr 19, 2018
Technical Presentation (December 2017)Technical28 slidesDec 5, 2017
Jefferies 2017 Global Healthcare ConferenceConference30 slidesJun 6, 2017
Technical Presentation (May 2017)Technical12 slidesMay 18, 2017
Technical Presentation (December 2016)Technical15 slidesDec 12, 2016
Technical Presentation (October 2015)Technical18 slidesOct 29, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Angus C. Russell
Other companies: Structure Therapeutics, Inc. (Director · Since at least Aug 26, 2024); Lineage Cell Therapeutics, Inc. (Director · Since at least Dec 12, 2014); TherapeuticsMD, Inc. (Director · Mar 18, 2015 – Sep 29, 2022 · Past); Mallinckrodt Inc (Director · Aug 14, 2014 – Jun 16, 2022 · Past); Questcor Pharmaceuticals Inc (Director · Jun 8, 2013 – Aug 14, 2014 · Past); InterMune Inc (Director · Oct 31, 2011 – Sep 29, 2014 · Past)
Director · Mar 4, 2014 – Feb 4, 2025 · Past
Vlad Coric
Other companies: Veradermics, Incorporated (Board Member · Since at least Feb 3, 2026); Royalty Pharma plc (Director · Since at least Apr 7, 2025); Biohaven Ltd. (Chairman & Chief Executive Officer · Since at least Sep 22, 2022); Akili Inc (Director · Jun 29, 2021 – Jun 29, 2021 · Past); Biohaven Pharmaceutical Holding Co Ltd (Chief Executive Officer, Director · May 3, 2017 – Oct 3, 2022 · Past)
Director · Mar 1, 2023 – Feb 4, 2025 · Past
Chris Nolet
Other companies: ArriVent BioPharma, Inc. (Director · Since at least Jan 25, 2024); Jasper Therapeutics, Inc. (Director · Since at least Sep 24, 2021); PolarityTE Inc. (Director · Apr 6, 2020 – Jan 12, 2023 · Past); Viela Bio Inc (Director · Oct 2, 2019 – Mar 15, 2021 · Past)
Director · Jul 16, 2019 – Feb 4, 2025 · Past
Ronald W Eastman
Other companies: Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); EyePoint, Inc. (Director · Mar 28, 2018 – Mar 28, 2018 · Past); Corium International Inc (Director · Apr 2, 2014 – Nov 27, 2018 · Past)
Director · Feb 5, 2014 – May 11, 2017 · Past
David Hollander
Other companies: Veradermics, Incorporated (Chief R&D Officer · Since at least Aug 10, 2026); Kiora Pharmaceuticals, Inc. (Director · Since at least Dec 13, 2021); Aerie Pharmaceuticals Inc. (Chief R&D Officer · Nov 11, 2019 – Feb 4, 2022 · Past)
CMO & Global Therapeutics Lead · Feb 27, 2024 – Feb 4, 2025 · Past
Jill Beraud
Other companies: Levi Strauss & Co (Director · Since at least Mar 20, 2019); Tiffany & Co (EXECUTIVE VICE PRESIDENT · Oct 13, 2014 – Jan 26, 2015 · Past); RTW Retailwinds Inc (Director · May 2, 2011 – Jun 16, 2014 · Past)
Director · Jun 4, 2019 – Feb 4, 2025 · Past
Julian Gangolli
Other companies: Outlook Therapeutics, Inc. (Director · Since at least Apr 20, 2020); Krystal Biotech, Inc. (Board Member · Since at least Mar 1, 2019); GW Pharmaceuticals plc (President, North America · Oct 1, 2018 – May 10, 2019 · Past)
Director · Jul 1, 2016 – Feb 4, 2025 · Past
Mark A Prygocki Sr
Other companies: Verrica Pharmaceuticals Inc. (Director · Since at least Jun 14, 2018); Clarus Therapeutics Holdings Inc (Director · Sep 9, 2021 – Jun 7, 2022 · Past); Medicis Pharmaceutical Corp (President · Feb 7, 2006 – Dec 7, 2012 · Past)
Director · May 12, 2014 – May 5, 2016 · Past
Arthur Peter Bertolino
Other companies: Innovation Pharmaceuticals Inc. (President and CMO, Director · Jun 30, 2017 – Sep 1, 2019 · Past); Cellceutix Corp (Pres. & Chief Medical Officer · Jun 30, 2016 – Jun 30, 2016 · Past)
EVP and Chief Medical Officer · Sep 2, 2014 – Nov 17, 2015 · Past
Caryn Gordon McDowell
Other companies: Quince Therapeutics, Inc. (Chief Legal & Adm. Officer · May 5, 2020 – Jun 6, 2022 · Past); Cytokinetics, Incorporated (GC & Chief Compliance Officer · May 18, 2016 – Feb 27, 2018 · Past)
SVP, GC & Secretary · May 1, 2018 – Feb 15, 2020 · Past
All 26 people
PersonSeat
Mark J. Foley
Other companies: Glaukos Corporation (Director · Since at least Dec 13, 2017); SI-BONE, Inc. (Director · Jun 13, 2019 – Jun 16, 2020 · Past)
President & CEO, Director · Nov 7, 2017 – Feb 4, 2025 · Past
Olivia Ware
Other companies: Contineum Therapeutics, Inc. (Director · Since at least Apr 4, 2024); Arcellx Inc (Director · Since at least May 16, 2022)
Director · Mar 6, 2021 – Feb 4, 2025 · Past
Philip J Vickers
Other companies: Akebia Therapeutics, Inc. (Director · Since at least Apr 1, 2026); Tectonic Therapeutic, Inc. (Director · Jan 7, 2019 – Jun 6, 2023 · Past)
Director · Feb 26, 2015 – May 4, 2022 · Past
Tobin Schilke
Other companies: Crinetics Pharmaceuticals, Inc. (Chief Financial & Infra. Ofcr. · Since at least Feb 28, 2025); Achaogen Inc (Chief Financial Officer · Jul 5, 2016 – Jun 26, 2018 · Past)
CFO · Nov 5, 2018 – Feb 4, 2025 · Past
Todd Erik Zavodnick
Other companies: Stablecoin Development Corporation (Director · May 9, 2016 – May 30, 2019 · Past); Zeltiq Aesthetics Inc (President, International · Feb 1, 2016 – Apr 28, 2017 · Past)
CCO & President, · Sep 18, 2017 – Oct 15, 2018 · Past
James Walter Glasheen
Other companies: Soleno Therapeutics, Inc. (Director · Jul 6, 2017 – Jun 11, 2018 · Past)
Director · Feb 5, 2014 – May 5, 2016 · Past
Robert F Byrnes
Other companies: Solta Medical Inc (Director · Nov 9, 2006 – Nov 15, 2006 · Past)
Director · Feb 5, 2014 – May 14, 2020 · Past
Ronald J Wooten
Other companies: Aceragen Inc. (Director · Sep 28, 2022 – Jan 17, 2023 · Past)
Director · Feb 5, 2014 – May 7, 2015 · Past
Abhay JoshiCOO, President of R&D · Dec 14, 2015 – Mar 15, 2022 · Past
Aubrey RankinDirector · Jul 23, 2020 – Mar 15, 2022 · Past
Carey OConnor KolajaDirector · May 1, 2024 – Feb 4, 2025 · Past
Curtis RueggEVP, Technical Operations · Feb 5, 2014 – Jun 13, 2016 · Past
Dustin S SjutsPresident · Dec 1, 2019 – Mar 15, 2024 · Past
Dwight MoxieCLO & GC · Feb 18, 2020 – Feb 4, 2025 · Past
Erica JordanChief Commercial Officer · Feb 27, 2024 – Feb 4, 2025 · Past
L Daniel BrowneCEO and President, Director · Feb 5, 2014 – Jun 28, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Revance Therapeutics, Inc.